Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-22-077433

Chief Scientific Officer sold 37,164 shares at $12.00 ($445,968)

  • Chief Scientific Officer acquired 27,769 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Roberts M Scot Chief Scientific Officer 2022-07-01 Option exercise +4,019 $2.60 $10,449 21,719 D
Roberts M Scot Chief Scientific Officer 2022-07-01 Option exercise +22,963 $2.95 $67,741 44,682 D
Roberts M Scot Chief Scientific Officer 2022-07-01 Sale −26,982 $12.00 $323,784 17,700 D
Roberts M Scot Chief Scientific Officer 2022-07-05 Option exercise +787 $2.95 $2,322 18,487 D
Roberts M Scot Chief Scientific Officer 2022-07-05 Sale −10,182 $12.00 $122,184 8,305 D
Derivatives
Roberts M Scot Chief Scientific Officer 2022-07-01 Option exercise · Stock Options (option to buy) −4,019 8,750 D
Roberts M Scot Chief Scientific Officer 2022-07-01 Option exercise · Stock Options (option to buy) −22,963 15,037 D
Roberts M Scot Chief Scientific Officer 2022-07-05 Option exercise · Stock Options (option to buy) −787 14,250 D
Open-market sales · 37,164 sh · avg $12.00 · $445,968
Loading xslF345X03/tm2220386-1_4seq1.xml…